eMedicine Specialties > Dermatology > Diseases of the Vessels

Venous Insufficiency

Author: Robert Weiss, MD, Associate Professor, Department of Dermatology, Johns Hopkins University School of Medicine,
Coauthor(s): Craig F Feied, MD, FACEP, FAAEM, FACPh, Professor of Emergency Medicine, Georgetown University School of Medicine; General Manager, Microsoft Enterprise Health Solutions Group
Contributor Information and Disclosures

Updated: Nov 15, 2009

Introduction

Background

In venous insufficiency states, venous blood escapes from its normal antegrade path of flow and refluxes backward down the veins into an already congested leg. Venous insufficiency syndromes are most commonly caused by valvular incompetence in the low-pressure superficial venous system but may result from valvular incompetence in the high-pressure deep venous system or rarely both. Untreated venous insufficiency in the deep or superficial system causes a progressive syndrome involving pain, swelling, skin changes, and eventual tissue breakdown.

Deep venous insufficiency occurs when the valves of the deep veins are damaged as a result of deep venous thrombosis (DVT). With no valves to prevent deep system reflux, the hydrostatic venous pressure in the lower extremity increases dramatically. This condition is often referred to as a postphlebitic syndrome.

Superficial venous incompetence is the most common form of venous disease. In superficial venous insufficiency, the deep veins are normal, but venous blood escapes from a normal deep system and flows backwards through dilated superficial veins in which the valves have failed.

The valves in superficial veins can fail for a variety of reasons. Most commonly, congenitally weak vein walls may dilate under normal pressures to cause secondary valve failure. Direct injury or superficial phlebitis may cause primary valve failure. Congenitally abnormal valves can also be incompetent at normal superficial venous pressures. Normal veins and normal valves may become excessively distensible under the influence of hormones (as in pregnancy).

Most cases of superficial vein valve failure occur after primary points of high-pressure leakage develop between the deep system and the superficial system. High pressure causes secondary valve failure when otherwise normal superficial veins become so widely dilated that the thin flaps of the venous valves can no longer make contact in the lumen of the vessel. Over time, these incompetent superficial veins become visibly dilated and tortuous, at which point they are recognized as varicose veins.

High pressure can enter the superficial veins as a result of the failure of key valves at any point of communication between the deep system and the superficial system. The 2 major sources of high-pressure leakage from the deep veins to the superficial system are junctional valve failure and perforator valve failure.

Junctional high-pressure disease most often results from failure of the primary valve at the junction between the greater saphenous vein and the common femoral vein at the groin (saphenofemoral junction). Vein incompetence then proceeds distally from the groin, and patients perceive that a large vein is growing down their leg. A less common form of junctional reflux results from failure of the primary valve at the junction between the short saphenous vein and the popliteal vein at the knee (saphenopopliteal junction).

Perforator high-pressure disease results from failure of the valves of any perforating vein. The most common sites of primary perforator valve failure are in the midproximal thigh (Hunterian perforator) and in the proximal calf (Boyd perforators). When the primary high-pressure entry point is distal, large clusters of veins are first noticed in the lower leg, with large veins eventually growing up the leg toward the groin.

Pathophysiology

When venous valves are working correctly, every movement of the leg causes blood to be pumped inward and upward past a series of valves. During ambulation, the normal pressure in the venous system of the lower leg is nearly zero. Immediately after ambulation, the early standing pressure in the normal leg remains low. Arterial inflow fills the leg veins slowly, and the only source of venous pressure is the hydrostatic pressure of a column of blood as high as the nearest competent valve. In venous insufficiency, after prolonged standing, the veins are completely filled, and all the venous valves float open. At this time, high hydrostatic venous pressure results from the unbroken column of fluid that extends from the head to the foot.

Failed valves cause the column of standing blood in the vein to remain high even when during ambulation. The hydrostatic pressure increases during and immediately after ambulation, which cause venous congestion.

High venous pressure is directly responsible for many aspects of venous insufficiency syndrome, including edema, tissue protein deposition, perivascular fibrin cuffing, red cell extravasation, impaired arterial inflow, and other locally mediated disturbances.

Not all of the sequelae of venous insufficiency are related to venous hypertension, and not all patients with venous hypertension develop ulceration. Some patients with venous ulceration do not have marked venous hypertension.

The poor clearance of lactate, carbon dioxide, and other products of cellular respiration also contribute to the development of the syndrome. A defect in the clearance of extraneous substances can be quantified: If albumin labeled with a radioactive tracer is injected into the foot tissues, the clearance rate is markedly slowed by deep venous obstruction or by deep or superficial venous incompetence. Although this effect is referred to as venous stasis, the reduced clearance of cellular metabolites is not always due to true venous stasis. In many cases, the venous blood is moving at a normal speed, but a local recirculation of this venous blood upward through normal veins and downward through varicosities prolongs the average transit time for the blood to pass from the heart and lungs through the legs and back to the central circulation.

The time required for an aliquot of radiolabeled blood to pass from the femoral artery through the leg and back to the central circulation is highly correlated with the development of leg ulcers. The aliquot transit time and the clearance time for an extremity are closely related to the volume of retrograde flow through refluxing veins. Superficial varicosities always produce venous recirculation and can result in prolonged clearance that may be localized or affect the whole leg. Experimental evidence shows that if the peak retrograde flows in the greater and short saphenous veins and popliteal vein add to less than 10 mL/s, progressive visible stasis dermatitis and ulceration do not occur. If the sum is greater than 15 mL/s, the incidence of ulceration is high. In some cases, purely superficial local reflux with a pressure of more than 7 mL/s can cause local ulceration.

Chronic nonhealing wounds of the lower extremity have many different potential causes, but most chronic lower-extremity ulcers are of venous etiology. Most venous ulcers are caused by venous reflux that is purely or largely confined to the superficial venous system. Only a minority are caused by chronic DVT or by valvular insufficiency in the deep veins.

Frequency

United States

Published estimates of the prevalence of varicosities range from 7-60% in the adult population, with most studies demonstrating clinical varicose reflux in about 40% of the population.1

International

The frequency of venous insufficiency is believed to be higher in Westernized and industrialized nations, most likely due to differences in lifestyle and activity.

Mortality/Morbidity

The syndromes of venous hypertension and reduced venous clearance are important causes of morbidity and disability in patients with varicose venous disease (see also Complications).

  • Chronic nonhealing leg ulceration can be debilitating. Approximately 1 million Americans have an ulceration due to superficial venous disease, and approximately 100,000 are disabled because of their condition.
  • As many as 50% of patients with untreated varicose veins develop superficial thrombophlebitis at some time. This is of grave concern, because unrecognized DVT is present in as many as 45% of patients with what appears to be purely superficial phlebitis. The risk of DVT is 3 times higher in patients with superficial varicosities than in the general population.
  • Bed rest and intercurrent illness place patients with venous insufficiency at higher risk for DVT. Phlebitis develops in 60% of hospitalized patients with clinically evident superficial venous insufficiency, and in nearly one half of cases, the condition progresses to DVT. Approximately one half of patients with DVT have detectable pulmonary embolism, and the mortality rate in this group exceeds 1 in 3.
  • Bleeding from lower-extremity varicosities can be fatal.2 Twenty-three such fatalities were reported in England and Wales in 1971, and although there is no central registry to tabulate the frequency with which it occurs, such cases are not unusual in the United States. Bleeding is not a rare problem, but often is managed incorrectly (see Medical Care).

Sex

  • The incidence and prevalence of deep and superficial venous disease depend on the age and sex of the population, but the prevalence in women exceeds that of men at any age.
  • In younger men, the incidence is less than 10%, compared with 30% in similarly aged women. In men over 50 years of age, the incidence is 20%, compared with 50% in similarly aged women.3

Age

The prevalence of venous insufficiency increases with age.

  • Reticular veins usually appear or are first noticed in adolescence and young adulthood, with only a small number of new cases developing after the childbearing years. Truncal varicosities and telangiectatic webs, on the other hand, are relatively less common in youth and can appear throughout life.
  • The Basle III study included a large number of children aged 10-12 years at one point and again 4 years later. The study revealed that symptoms and abnormal venous test results occur before any abnormal veins are visible at the surface. Abnormal reticular veins appear first and are followed by incompetent perforators and truncal varicosities, which appear several years later.

Clinical

History

Patients with venous insufficiency often report subjective symptoms that are typically bothersome early in the disease, become less severe in the middle phases, and then worsen again with advancing age.

  • Even small telangiectasias are often symptomatic. More than one half of patients who present with telangiectasias smaller than 1 mm in diameter report symptoms that abate after treatment. Common symptoms include the following:
    • Burning
    • Swelling
    • Throbbing
    • Cramping
    • Aching
    • Heaviness
    • Restless legs
    • Leg fatigue
  • Subjective complaints are also common in patients with truncal varices; 18% of patients with varicosities report frequent or continuous symptoms, while almost 50% complain of episodic symptoms.
  • Patients with deep system insufficiency nearly always are symptomatic. Leg aching, heaviness, and soreness are the most common subjective symptoms.
  • Episodic pain and other symptoms associated with superficial venous disease may be temporally related to hormonal changes, both physiologic and pharmacologic.
  • One half of all pregnant women with varicose veins complain of pain, and 17% are unable to remain upright for more than 1-2 hours at a time because of its severity.
  • Pain caused by venous insufficiency often is improved by walking or by elevating the legs.
    • Warmth tends to aggravate the symptoms of venous insufficiency, and cold tends to relieve them.
    • Compression stockings usually ameliorate or prevent the pain of venous insufficiency.
  • In many ways, the behavior of the pain caused by arterial insufficiency is the opposite to the behavior of the pain caused by venous insufficiency.
    • The pain of arterial insufficiency usually is worse with walking and worse when the legs are elevated.
    • Cold tends to aggravate the symptoms, whereas warmth tends to relieve them.
    • Compression stockings usually aggravate the pain of arterial insufficiency.
  • The pain of venous obstruction is worse with walking or warmth but better with elevation of the legs. Compression stockings usually improve the pain of venous obstruction.

Physical

The visual appearance of the lower extremities is a useful but not always reliable guide to the peripheral venous condition.4 Clinical findings in venous disease are also common to many other entities that affect the lower extremities. Physical examination alone is not a reliable means of assessing the venous system. Diagnostic testing nearly always is necessary to rule out deep venous obstruction, to assess the paths of reflux, and to guide treatment planning. The Trendelenburg test is traditionally part of the physical examination and may be helpful in making the differential diagnosis (see Procedures).

  • Swelling may result from acute venous obstruction (as in DVT) or deep or superficial venous reflux. Alternatively, swelling may be completely unrelated to the venous system.
    • Lower-extremity pitting edema is common in patients with venous insufficiency.
    • Hepatic insufficiency, renal failure, cardiac decompensation, infection, trauma, and environmental effects can also cause lower-extremity pitting edema that may be indistinguishable from the edema due to venous obstruction or venous insufficiency.
    • Lymphatic edema may be a sign of primary lymphatic outflow obstruction, or it may be secondary to the overproduction of lymph due to severe venous hypertension (a so-called venolymphatic syndrome).
  • Skin discoloration may be a sign of venous stasis, arterial insufficiency, chronic infection, prior injury, or a host of other conditions (see Media File 1).

  • Superficial venous insufficiency with skin change...

    Superficial venous insufficiency with skin changes.

    Superficial venous insufficiency with skin change...

    Superficial venous insufficiency with skin changes.

  • Nonhealing ulcerations (see Media File 2) may be due to deep or superficial venous insufficiency. Other causes include arterial insufficiency, rheumatologic disorders, local trophic effects, unrecognized cancer, or other more exotic causes.

  • Ulcer due to venous insufficiency.

    Ulcer due to venous insufficiency.

    Ulcer due to venous insufficiency.

    Ulcer due to venous insufficiency.

  • The most common physical signs of venous insufficiency are those attributed to the progressive syndromes of chronic venous stasis and chronic venous hypertension. These signs include the following:
    • Edema
    • Hyperpigmentation
    • Venous dermatitis
    • Chronic cellulitis
    • Cutaneous infarction (atrophie blanche)
    • Ulceration
  • A long-standing venous ulcer rarely converts to a basal cell carcinoma or squamous cell carcinoma. The venous ulcer may develop collision lesions (eg, basal cell carcinoma and stasis ulceration) at the same site.
  • Normal veins are visibly distended at the foot and ankle and, occasionally, in the popliteal fossa.
    • Normal veins are usually not visibly distended in the rest of the leg. Translucent skin may cause the normal veins to become visible in a bluish subdermal reticular pattern.
    • A dilated vein above the ankle is usually evidence of venous pathology.
  • Darkened, discolored, and stained skin is often a sign of chronic venous stasis, particularly if it is localized along the medial part of the ankle or the medial aspect of the lower leg.
    • These areas are especially prone to venous hypertension because their drainage largely depends on the competence and patency of the entire length of the greater saphenous vein and all of the perforating veins attached to it.
    • Nonhealing ulcers on the medial part of the ankle are most likely due to underlying venous stasis.
  • Skin changes or ulcerations that are localized to the lateral aspect of the ankle are more likely to be related to prior trauma or arterial insufficiency than to pure venous insufficiency.

Causes

The sequelae of venous insufficiency are caused by reflux through superficial or deep veins or by venous outflow obstruction. Most cases of venous insufficiency are related to reflux through the superficial veins.

  • Superficial venous insufficiency is most often caused by the failure of a valve in the superficial venous system. Greater than 80% of varicose veins seen on the leg are caused by venous insufficiency or a leaky valve in the great saphenous vein, which terminates near the inguinal ligament as it joins the common femoral vein.
    • The initial valve failure may occur at any level between the groin and the ankle, but the saphenofemoral junction is the high point of reflux in most patients with severe superficial venous insufficiency.
    • Valve failure can be spontaneous in patients with congenitally weak valves.
    • Congenitally normal valves can fail due to direct trauma, thrombosis, hormonal changes, or chronic environmental insult (eg, prolonged standing).
  • Deep venous insufficiency can be due to congenital valve or vessel abnormalities, but DVT is the most common cause of deep system valve injury.
  • A less common cause of venous insufficiency is Klippel-Trenaunay-Weber (KTW) syndrome, which involves port-wine stains, varicose veins, and bony or soft-tissue hypertrophy. Patients with pure Klippel-Trenaunay syndrome have only venous involvement, whereas those with the Parkes Weber variant also have arteriovenous malformations.
    • Like those of other forms of venous insufficiency, the capillary hemangiomas (port-wine stains) of KTW syndrome can lead to local skin breakdown and ulceration, bleeding, and secondary infection. This can occur in any organ system of the body.
    • The KT, or sciatic vein, is a large superficial vessel that is present during fetal development, but it usually does not persist. In patients with KTW syndrome, this vein may be noticed at birth, or it may become apparent later in life. The vein extends along the posterolateral aspect of the leg from the foot to the gluteal region. When present, it is invariably a reflux pathway rather than a pathway for antegrade flow.
    • Patients with KTW syndrome may have atresia of the deep veins as well as many abnormal venous pathways involving the deep and superficial venous systems.
    • Surgical attempts to treat the abnormal refluxing veins in KTW syndrome are fraught with peril because postoperative worsening of venous abnormalities is common.
    • KTW syndrome can produce such severe venous insufficiency that the otherwise normal lymphatic system becomes overwhelmed by the amount of lymph production, which leads to secondary lymphedema.

More on Venous Insufficiency

Overview: Venous Insufficiency
Differential Diagnoses & Workup: Venous Insufficiency
Treatment & Medication: Venous Insufficiency
Follow-up: Venous Insufficiency
Multimedia: Venous Insufficiency
References

References

  1. Coon WW, Willis PW 3rd, Keller JB. Venous thromboembolism and other venous disease in the Tecumseh community health study. Circulation. Oct 1973;48(4):839-46. [Medline].

  2. Racette S, Sauvageau A. Unusual sudden death: two case reports of hemorrhage by rupture of varicose veins. Am J Forensic Med Pathol. Sep 2005;26(3):294-6. [Medline].

  3. Chiesa R, Marone EM, Limoni C, Volonte M, Schaefer E, Petrini O. Chronic venous insufficiency in Italy: the 24-cities cohort study. Eur J Vasc Endovasc Surg. Oct 2005;30(4):422-9. [Medline].

  4. Bonnetblanc JM. Leg ulcerations: a clinical appraisal. Eur J Dermatol. May-Jun 2005;15(3):127-32. [Medline].

  5. Zimmet SE. Venous leg ulcers: modern evaluation and management. Dermatol Surg. Mar 1999;25(3):236-41. [Medline].

  6. Sadick NS. Advances in the treatment of varicose veins: ambulatory phlebectomy, foam sclerotherapy, endovascular laser, and radiofrequency closure. Dermatol Clin. Jul 2005;23(3):443-55, vi. [Medline].

  7. Tretbar LL. Treatment of small bleeding varicose veins with injection sclerotherapy. Bleeding blue blebs. Dermatol Surg. Jan 1996;22(1):78-80. [Medline].

  8. Nijsten T, van den Bos RR, Goldman MP, et al. Minimally invasive techniques in the treatment of saphenous varicose veins. J Am Acad Dermatol. Jan 2009;60(1):110-9. [Medline].

  9. Nael R, Rathbun S. Treatment of varicose veins. Curr Treat Options Cardiovasc Med. Apr 2009;11(2):91-103. [Medline].

  10. Leopardi D, Hoggan BL, Fitridge RA, Woodruff PW, Maddern GJ. Systematic review of treatments for varicose veins. Ann Vasc Surg. Mar 2009;23(2):264-76. [Medline].

  11. Diehm C, Allenberg JR. Color Atlas of Vascular Diseases. New York, NY: Springer Publishing; 1999:1-396.

  12. Feied CF. Deep vein thrombosis: the risks of sclerotherapy in hypercoagulable states. Semin Dermatol. Jun 1993;12(2):135-49. [Medline].

  13. Feied CF. Peripheral venous disease. In: Rosen and Barkin, eds. Emergency Medicine Principles and Practice. Vol 3. 4th ed. St. Louis, Mo: Mosby-Year Book; 1998:Chapter 107.

  14. Goldman MP. Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. 2nd ed. St. Louis, Mo: Mosby-Year Book; 1995:1-519.

  15. Weiss RA, Feied CF, Weiss MA. Vein Diagnosis & Treatment: A Comprehensive Approach. New York, NY: McGraw-Hill; 2001:1-304.

Further Reading

Keywords

venous insufficiency, venous stasis, postphlebitic syndrome, venous reflux, stasis dermatitis, stasis ulcer, venous ulcer, valvular incompetence, DVT, deep vein thrombosis, deep venous thrombosis, superficial venous incompetence, superficial venous insufficiency, varicose veins, junctional high-pressure disease, perforator high-pressure disease, venous hypertension

Contributor Information and Disclosures

Author

Robert Weiss, MD, Associate Professor, Department of Dermatology, Johns Hopkins University School of Medicine,
Robert Weiss, MD is a member of the following medical societies: American Academy of Cosmetic Surgery, American Academy of Dermatology, American College of Phlebology, American Dermatological Association, American Society for Dermatologic Surgery, American Society for Laser Medicine and Surgery, and MedChi
Disclosure: Angiodynamics Honoraria Speaking and teaching; CoolTouch Corp Intellectual property rights Consulting; Cynosure Grant/research funds Independent contractor; Palomar Grant/research funds Independent contractor

Coauthor(s)

Craig F Feied, MD, FACEP, FAAEM, FACPh, Professor of Emergency Medicine, Georgetown University School of Medicine; General Manager, Microsoft Enterprise Health Solutions Group
Craig F Feied, MD, FACEP, FAAEM, FACPh is a member of the following medical societies: American Academy of Emergency Medicine, American College of Emergency Physicians, American College of Phlebology, American College of Physicians, American Medical Association, American Medical Informatics Association, American Venous Forum, Medical Society of the District of Columbia, Society for Academic Emergency Medicine, and Undersea and Hyperbaric Medical Society
Disclosure: Nothing to disclose.

Medical Editor

R Stan Taylor, MD, Professor of Dermatology, University of Texas Southwestern Medical School; Director of Skin Surgery and Oncology Clinic, Department of Dermatology, University of Texas Southwestern Medical Center
R Stan Taylor, MD is a member of the following medical societies: American Academy of Dermatology, American College of Mohs Surgery, American Dermatological Association, American Medical Association, American Society for Dermatologic Surgery, Christian Medical & Dental Society, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.

Pharmacy Editor

Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.

Managing Editor

Mary Farley, MD, Dermatologic Surgeon/Mohs Surgeon, Anne Arundel Surgery Center
Disclosure: Nothing to disclose.

CME Editor

Glen H Crawford, MD, Assistant Clinical Professor, Department of Dermatology, University of Pennsylvania School of Medicine; Chief, Division of Dermatology, The Pennsylvania Hospital
Glen H Crawford, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, Phi Beta Kappa, and Society of USAF Flight Surgeons
Disclosure: Nothing to disclose.

Chief Editor

Dirk M Elston, MD, Director, Department of Dermatology, Geisinger Medical Center
Dirk M Elston, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.